Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the VeraCept Intrauterine Device for Long Acting Reversible Contraception

NCT02167763 is registered in ClinicalTrials.gov with Sebela Women's Health Inc. as lead sponsor.

NCT NCT02167763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02167763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the VeraCept Intrauterine Device for Long Acting Reversible Contraception
Lead sponsor
Sebela Women's Health Inc.
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2013
Completion date
December 31, 2017
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prevention of pregnancy